Interval-to-residual curve with half-life uncertainty ribbonLive current inputs
Health & Fitness
Medication Interval Target Range Calculator
Calculate the mathematical interval band corresponding to an entered residual-fraction corridor under a generic first-order half-life model, then compare it with a label interval without changing it.
Mathematical interval band—
Residual at label interval—
Label comparison—
Residual uncertainty at label interval—
Time to comparison residual—
Label events in horizon—
Absorption-lag share—
Decision boundary—
RESIDUAL-FRACTION RESPONSE
Interval-to-residual curve with half-life uncertainty ribbon
The prescription interval is a reference marker on the response curve, not an optimization output.
SENSITIVITY GRID
Residual fraction across interval and half-life cases
The grid shows why one half-life cannot define a universally correct dosing interval.
| Interval scenario | Short half-life residual | Reference residual | Long half-life residual | Corridor relation | Label relation |
|---|
SENSITIVITY SETUP
Keep clinical limits outside the equation
- Use a drug reference only to understand the generic decay shape.
- Enter the actual labeled or prescribed interval as a comparison marker.
- Treat half-life uncertainty as a sensitivity exercise.
- Do not interpret the residual corridor as a therapeutic window.
MATHEMATICAL RANGE VERSUS SAFE RANGE
An inverse-decay interval is not a dosing recommendation
The calculated band answers only: when would this simple model cross the entered residual fractions?
Safe and effective intervals depend on concentration-effect relationships, formulation, organ function, interactions, and clinical evidence that this page does not model.
INVERSE DECAY
Solve the exponential equation for a mathematical interval
Inverting the decay function yields an educational time band. It does not yield a clinically acceptable interval.
Detailed calculation process and general formulas
k = ln(2) / t_halfResidual(τ) = e^(-kτ)τ(r) = -ln(r) / kBand_τ = [τ(residualHigh), τ(residualLow)]N_events = floor(24×days / labelInterval) + 1Symbols, meanings, and units
- r
- entered residual fractiondecimal
- τ(r)
- mathematical time to residual rhours
- k
- elimination-rate constant1/hour
- Band_τ
- intervals corresponding to residual corridorhours
- N_events
- reference events over scenario horizoncount
RANGE INTERPRETATION
Keep the three bands conceptually separate
The visualization distinguishes them explicitly.
Residual corridor
—User-entered fractions define a mathematical horizontal band.
Half-life ribbon
—Uncertainty shows model sensitivity at the label interval.
Prescription marker
—The actual interval remains a non-optimized reference.
Decision takeaway: The product label and prescriber govern the interval; the curve only explains first-order decay sensitivity.
Applied decisions
Educational sensitivity comparisons
Wide half-life uncertainty
The same label interval intersects a broad residual ribbon.
What the result clarifies: Patient and study variability can matter more than a single nominal half-life.
Residual corridor moved
The user changes the illustrative residual fractions.
What the result clarifies: The inverse mathematical band moves, demonstrating that it is assumption-dependent.
Worked default scenario
Current-input substitution and reconciliation
Method references
Evidence used to frame this specific model
Scope and limitations
Not a medication interval selector. The residual corridor is an educational assumption, not a therapeutic target. Never alter a prescribed schedule from this result.
Medication Interval Target Range Calculator | Residual-Fraction Sensitivity FAQ
Is the interval band a safe dosing range?
No. It is only the inverse of a simplified exponential residual equation.
Why compare with a label interval?
To keep the factual prescribed schedule visible while exploring model sensitivity.
Does absorption lag change elimination half-life?
Not in this simple display; it is reported separately as a timing limitation.
Can this model handle extended-release products?
No. Extended absorption and multiple compartments require drug-specific models.